Vaccine Research

welcome message

We are pleased to welcome participants from around the world to the 7^th International Conference on Vaccine Research taking place on November 16–17 2026 in Tokyo Japan. Under the theme "Innovating Vaccines for Global Health Protection and Disease Prevention" the conference will bring together researchers scientists healthcare professionals academicians and industry experts to discuss the latest developments in vaccine research immunology and disease prevention.

Vaccine congress 2026 provides an excellent platform to explore recent advances and future directions in vaccinology infectious disease prevention biotechnology clinical research and public health. We are honored to host distinguished speakers and leading experts who will share their knowledge research findings and practical experiences through keynote lectures scientific sessions and interactive discussions.

This conference is dedicated to promoting scientific exchange and encouraging collaboration in vaccine research and development. It offers valuable opportunities for participants to present their work gain new insights discuss emerging challenges and build professional connections. We look forward to welcoming you to Tokyo Japan for an engaging and rewarding scientific experience.

About Conference

Abstract Submission and Registration Process

Participants from academia research institutions healthcare organizations biotechnology industry pharmaceutical sector and public health agencies are invited to submit original contributions including abstracts full manuscripts case reports posters and digital poster presentations aligned with vaccine research immunology vaccinology and global immunization themes.

Submission Guidelines

Submissions must be limited to a maximum of 500 words.
The title should be formatted in sentence case style.
Complete details of authors including full names and institutional affiliations must be provided.
A concise author profile up to 150 words along with a recent passport size photograph should be included.

Review Process

All submitted abstracts will be evaluated by the Scientific Committee Members. Acceptance confirmation or feedback will be shared via email within 24–48 hours after submission.

Registration

The 7^th International Conference on Vaccine Research serves as a global scientific platform dedicated to advancing vaccine development immunology vaccinology infectious disease prevention and public health innovation. This two day conference is designed to encourage knowledge sharing scientific collaboration and professional development through high quality presentations and expert discussions.

How to Register

Visit the registration page to explore available options and complete your registration. Join leading scientists researchers clinicians and industry professionals from around the world for this international gathering focused on vaccine science and global health advancement.

Publication Opportunity

Accepted abstracts will be included in conference proceedings and selected submissions will be considered for publication in affiliated journals ensuring wider dissemination of research contributions.

Abstract Submission URL: https://vaccines.annualcongress.com/abstract-submission.php

Sessions and Tracks

Track 1: Vaccine Discovery and Development

Vaccine Discovery and Development focuses on the complete scientific process of identifying antigens designing vaccine candidates and advancing them through laboratory and clinical stages. It combines immunology molecular biology genomics and bioinformatics to understand disease mechanisms and create effective preventive solutions. Researchers apply advanced technologies such as reverse vaccinology structural biology and computational modeling to accelerate vaccine innovation. This process includes antigen selection formulation testing and preclinical evaluation to ensure safety immunogenicity and efficacy. The ultimate goal is to develop safe effective and accessible vaccines that protect populations from infectious diseases and emerging health threats.

• Target antigen identification
• Epitope mapping and analysis
• Preclinical vaccine evaluation
• Reverse vaccinology approaches
• Computational vaccine design

Track 2: Clinical Vaccinology and Immunization Practice

Clinical Vaccinology and Immunization Practice focuses on the real world application of vaccines in healthcare systems. It ensures safe administration correct dosing schedules and monitoring of vaccine outcomes in diverse populations. Healthcare professionals work together to improve immunization coverage reduce vaccine hesitancy and strengthen public awareness. This field also addresses adverse event management post vaccination surveillance and cold chain maintenance. It plays a vital role in protecting communities and improving global disease prevention strategies through effective vaccination programs.

• Vaccine administration protocols
• Immunization scheduling systems
• Adverse event monitoring and reporting
• Vaccine counseling and education
• Community immunization programs

Track 3: Biotechnology and Vaccine Engineering

Biotechnology and Vaccine Engineering focuses on using genetic engineering cell based systems and biotechnological tools to develop advanced vaccine platforms. It enables production of recombinant vaccines mRNA vaccines viral vector vaccines and protein subunit vaccines. Researchers work on improving expression systems purification methods and large scale production efficiency. This field significantly enhances vaccine safety stability and scalability while reducing production time. It plays a crucial role in developing modern vaccines for infectious diseases and pandemic preparedness.

• mRNA vaccine technology development
• Recombinant protein vaccines
• Viral vector vaccine platforms
• Protein subunit vaccine systems
• Cell culture based vaccine production

Track 4: Immunology and Host Immune Response

Immunology and Host Immune Response focuses on understanding how the immune system reacts to vaccines and infectious agents. It studies innate immunity adaptive immunity antibody production and immune memory formation. Researchers investigate how vaccines activate T cells B cells and cytokine pathways to produce long lasting protection. This knowledge helps improve vaccine effectiveness and design strategies for stronger immune responses. It is essential for developing vaccines against complex and emerging pathogens.

• Innate immune response mechanisms
• Adaptive immunity and antibody production
• T cell mediated immunity
• Cytokine signaling pathways
• Immune memory development

Track 5: Vaccine Design and Molecular Biology

Vaccine Design and Molecular Biology focuses on the structural and genetic design of vaccine components for improved immune response. It integrates molecular genetics protein engineering and structural biology to optimize antigen design. Researchers study how molecular interactions influence immune activation and vaccine effectiveness. This field helps improve antigen stability specificity and immune recognition. It plays a key role in designing next generation precision vaccines.

• Protein engineering and modification
• Genetic vaccine construction
• Molecular structure analysis
• Antigen optimization strategies
• Structural vaccinology techniques

Track 6: Vaccine Delivery Systems and Formulations

Vaccine Delivery Systems and Formulations focus on improving how vaccines are transported stored and administered to maximize effectiveness. It includes development of novel delivery carriers adjuvants and controlled release systems. Researchers work on enhancing stability bioavailability and immune response efficiency. This field explores innovative technologies such as nanoparticles microneedles and oral delivery systems. It ensures vaccines remain effective from production to administration.

• Adjuvant development and optimization
• Nanoparticle based delivery systems
• Oral and mucosal vaccine delivery
• Injectable and controlled release formulations
• Thermal stability enhancement systems

Track 7: Regulatory Affairs and Vaccine Approval Systems

Regulatory Affairs and Vaccine Approval Systems focus on ensuring vaccines meet global standards for safety quality and effectiveness. It involves regulatory documentation clinical evaluation approval processes and post approval monitoring. Experts coordinate with agencies such as WHO, FDA and EMA for compliance and authorization. This field ensures ethical development transparent approval and safe distribution of vaccines worldwide. It builds public trust and ensures regulatory integrity.

• FDA and WHO regulatory guidelines
• Vaccine approval and licensing process
• Clinical documentation requirements
• Compliance and ethical standards
• Post approval surveillance systems

Track 8: Clinical Trials and Vaccine Evaluation

Clinical Trials and Vaccine Evaluation focus on structured human studies that assess vaccine safety immunogenicity and effectiveness. It includes Phase I II and III trials along with real world evidence studies. Researchers use statistical modeling and ethical frameworks to ensure reliable results. This field plays a critical role in vaccine approval and policy development. It ensures vaccines provide measurable protection before global deployment.

• Phase I II III clinical trials
• Randomized controlled trial design
• Biostatistical evaluation
• Ethical review processes
• Real world evidence studies

Track 9: Nanotechnology in Vaccine Delivery

Nanotechnology in Vaccine Delivery focuses on nanoscale systems that enhance vaccine targeting and immune response. It enables precise delivery of antigens using nanoparticles lipid carriers and nano emulsions. These systems improve stability bioavailability and controlled release. Researchers are developing smart nanocarriers that respond to biological signals. This field revolutionizes vaccine efficiency and safety.

• Nanoparticle vaccine carriers
• Lipid based nanodelivery systems
• Nano emulsions and nanocapsules
• Targeted antigen delivery systems
• Smart responsive nanocarriers

Track 10: Vaccine Safety and Pharmacovigilance

Vaccine Safety and Pharmacovigilance focuses on monitoring and evaluating vaccine safety before and after approval. It ensures detection reporting and analysis of adverse events following immunization. Researchers use surveillance systems and data analytics to assess risk benefit balance. This field is essential for maintaining public confidence in vaccination programs. It strengthens global vaccine safety systems.

• Adverse event reporting systems
• Post vaccination surveillance
• Risk benefit analysis
• Safety data monitoring
• Signal detection systems

Track 11: Public Health and Immunization Policy

This topic focuses on vaccination strategies and policy frameworks that support global immunization programs. It addresses vaccine access coverage equity and healthcare system integration. Experts discuss disease prevention strategies outbreak control and health policy development. It plays a vital role in strengthening global public health infrastructure.

• Vaccination policy development
• Global immunization strategies
• Health system strengthening
• Disease prevention programs
• Public health planning

Track 12: Viral and Bacterial Vaccine Research

Viral and Bacterial Vaccine Research focuses on developing vaccines against infectious pathogens including viruses bacteria and emerging strains. It studies pathogen biology immune evasion mechanisms and host interactions. Researchers aim to create vaccines for epidemic and pandemic preparedness. This field is critical for global infectious disease control.

• Viral vaccine development
• Bacterial vaccine research
• Pathogen structure studies
• Epidemic prevention strategies
• Pandemic preparedness models

Track 13: Next Generation Vaccines and Emerging Technologies

This field explores cutting edge vaccine platforms including mRNA, DNA, peptide and synthetic vaccines. It integrates artificial intelligence synthetic biology and genomic tools to accelerate vaccine development. Researchers aim to create faster safer and more adaptable vaccines. It represents the future of vaccinology.

• mRNA and DNA vaccine platforms
• Synthetic biology approaches
• Peptide based vaccines
• AI driven vaccine design
• Rapid response vaccine systems

Track 14: Industrial Vaccine Manufacturing and Scale Up

This research area focuses on large scale vaccine production bioprocess optimization and global distribution systems. It includes automation quality control cold chain logistics and supply chain management. Researchers improve efficiency cost effectiveness and production scalability. It ensures global vaccine availability during outbreaks.

• Vaccine manufacturing scale up
• Bioprocess engineering systems
• Automation and robotics in production
• Cold chain logistics management
• Supply chain optimization

Track 15: Biostatistics and Epidemiology in Vaccine Research

This topic focuses on statistical analysis and disease modeling to support vaccine development and public health decisions. It studies disease spread vaccination impact and outbreak prediction. Researchers use mathematical models and data science tools. It strengthens evidence based vaccine strategies.

• Epidemiological modeling systems
• Disease surveillance analysis
• Statistical data interpretation
• Outbreak prediction models
• Vaccine impact assessment

Track 16: Global Health and Vaccine Equity

This field focuses on fair and equal access to vaccines across all populations. It addresses global disparities immunization coverage and healthcare accessibility. Experts explore international collaboration and policy development. It ensures equitable vaccine distribution worldwide.

• Vaccine access and distribution
• Global health partnerships
• Healthcare equity strategies
• International immunization programs
• Public health collaboration

Track 17: Artificial Intelligence in Vaccine Research

Artificial Intelligence in Vaccine Research focuses on computational tools that accelerate vaccine discovery and optimization. It uses machine learning predictive analytics and big data to identify vaccine targets. AI improves accuracy efficiency and speed in vaccine development. It is transforming modern vaccinology.

• AI driven vaccine design
• Machine learning models
• Predictive immune response analysis
• Big data analytics
• Automation in research

Track 18: Personalized Vaccinology and Precision Immunization

This research area focuses on tailoring vaccines based on individual genetic immune and biomarker profiles. It improves vaccine effectiveness and reduces variability in immune response. Researchers study pharmacogenomics and personalized immunization strategies. It represents the future of individualized healthcare.

• Genetic based vaccine response
• Immune profiling techniques
• Biomarker analysis
• Personalized immunization strategies
• Targeted vaccine design

Track 19: Emerging Trends in Vaccine Science

This research area explores modern innovations shaping the future of vaccine research. It includes digital health technologies smart vaccines blockchain systems and 3D vaccine printing. Researchers focus on improving vaccine accessibility efficiency and monitoring systems. It defines the future direction of vaccinology.

• Digital vaccine monitoring systems
• Smart vaccine technologies
• Blockchain in immunization records
• 3D printed vaccines
• Future healthcare innovations

Track 20: Advanced Vaccine Research and Innovation

Advanced Vaccine Research focuses on breakthrough scientific discoveries in immunology biotechnology and clinical science. It integrates multidisciplinary approaches to solve global health challenges. Researchers develop innovative vaccine platforms and translational solutions. It drives the next era of vaccine innovation.

• Experimental vaccine studies
• Biomedical innovation research
• Translational immunology
• Novel vaccine platforms
• Advanced clinical research

Market Analysis

Global Vaccine Research Market Growth (2024–2030)

The global vaccine research market is expected to grow significantly from 2024 to 2030 due to rising infectious disease threats and increasing demand for advanced preventive healthcare solutions. Expanding immunization programs, strong investments in biotechnology, and rapid progress in vaccine platforms such as mRNA and recombinant technologies are driving market expansion. Growing focus on pandemic preparedness, global health security, and personalized vaccination approaches is further supporting development. Collaboration among research institutions, pharmaceutical industries, and public health organizations is accelerating innovation and vaccine availability. Improvements in manufacturing capacity, regulatory support, and global distribution systems are also strengthening the overall vaccine research ecosystem worldwide.
                                 

Key Drivers of Market Growth by 2030

Key factors driving market growth include the rising prevalence of infectious diseases, increasing awareness of vaccination benefits, and strong government support for immunization programs. Advances in artificial intelligence, genomics, bioinformatics and vaccine engineering are enabling faster and more efficient vaccine development. Growing demand for next-generation vaccines, improved delivery systems, and precision immunization strategies is enhancing vaccine effectiveness and accessibility. Expansion of global health initiatives, pandemic preparedness programs, and funding for biomedical research is further boosting innovation. Continued collaboration between healthcare organizations, academia, and industry is expected to strengthen global vaccine research and improve public health outcomes.
                                  

Visa Guidelines

Planning a Trip to Tokyo, Japan? Attend Our Conference!

We are pleased to support international participants with the visa application process for attending the 7^th International Conference on Vaccine Research in Tokyo, Japan. To assist delegates in obtaining their visa, we provide the following official supporting documents:

• Official Letter of Invitation (Visa Support Letter)
• Official Abstract Acceptance Letter (for presenters)
• Registration Payment Receipt

Important Notes

The Visa Invitation Letter will be issued only after successful conference registration and payment confirmation.
Visa support documents will be provided exclusively to participants who have been officially registered for the conference.

How to Request a Visa Letter

To request your Visa Invitation Letter, please contact the Program Coordinator:

Email: meevents@memeetings.com
WhatsApp: +44 7735038467

When requesting the Visa Letter, kindly include the following details:

• Full name (as mentioned in passport)
• Scanned copy of passport (showing passport number and date of birth)
• Abstract Acceptance Letter (for presenters)

Registration payments can be completed through:

• Online Payment Gateway (Stripe)
• Bank-to-Bank Transfer

If you face any issues during registration or payment, please contact the Program Coordinator via email at meevents@memeetings.com or WhatsApp at +44 7735038467.

The 7^th International Conference on Vaccine Research 2026 organizing team will issue an official invoice to support bank transfer payments if required.

We look forward to welcoming you to Tokyo, Japan for the 7^th International Conference on Vaccine Research 2026.

Past Conference

The 6^th International Conference on Vaccine Research was part of a globally recognized conference series that has evolved into one of the most established scientific gatherings in the field of vaccinology. This prestigious event was successfully held on April 10–11, 2025, in Dubai, UAE, bringing together leading researchers, healthcare professionals, industry experts, policymakers, and emerging scientists from across the world.

With the theme “Advancing Vaccine Science for Global Health and Innovation,” the conference served as a high-impact platform for scientific exchange and collaboration. The event welcomed over 3,000 participants, along with more than 280 expert speakers, 150+ exhibitors, and numerous start-up innovators over a two-day program.

The congress featured multiple scientific areas covering the entire vaccine development pipeline. Discussions ranged from early-stage research and immunological studies to large-scale manufacturing, regulatory frameworks, and global distribution strategies. The meeting provided an integrated view of the vaccine ecosystem where scientific research, healthcare systems, industry stakeholders, and government representatives came together to accelerate innovation and public health impact.

The conference delivered a comprehensive scientific experience, making it a key global meeting point for experts working in vaccine development, immunization strategies, and emerging biomedical technologies. It created strong opportunities for collaboration, knowledge sharing, and advancement of vaccine science on an international scale.